据阿尔及利亚Algérie360网站12月3日报道，阿正持续推进医药自主战略，在胰岛素、抗 癌药物及激素类药物等关键领域取得重要成绩，并逐步向多个非洲国家出口国产药 品。阿的医药产业正迈向"主权化"和国际化的双重轨道。 （原标题：阿尔及利亚构建医药自主体系） 阿目前已拥有超过230家制药企业和780条生产线。这是该国医药产业增长的关键 指标，也体现了阿方希望成为非洲与地中海地区重要制药中心的战略意图。 阿医药工业部监察总长介绍了国家医药产业的发展方向。阿正大规模扩大本地生产能 力、吸引全球药企技术，并将卫生主权建设作为产业政策核心之一。阿方正与多家国 际领先实验室建立战略性合作伙伴关系，目标是获取最新的国际医药创新技术。他宣 布，国家已批准 100 个新的医药生产项目，这些项目将显著加强本土生产能力，并提 高国产药品的质量水平。 ...

Group 1 - The core point of the news is that President Trump has threatened pharmaceutical companies with a potential 200% tariff on imported drugs, but the market has reacted calmly due to the provided grace period for companies to adjust [1][2] - The grace period of "one to one and a half years" allows pharmaceutical companies ample time to stockpile and shift production, significantly reducing investor concerns [1][2] - Major pharmaceutical companies are already taking proactive measures, such as stockpiling drugs and increasing domestic production investments, indicating that industry confidence remains intact despite tariff threats [1][3] Group 2 - The grace period could extend until 2027, and companies may further extend their response time to 2028 through stockpiling, providing a strategic planning window for long-term adjustments [2] - The pharmaceutical industry is accelerating stockpiling, with hormone drug exports from Ireland to the U.S. valued at $36 billion this year, more than double last year's total [3] - Companies like Eli Lilly are investing heavily in U.S. manufacturing, with a $27 billion expansion plan, and tax incentives from Trump's "Big Beautiful Plan" are helping to mitigate the costs of establishing new facilities [3]

Core Viewpoint - The case of a young patient developing cataracts due to long-term use of steroid medications highlights the potential risks associated with such treatments, particularly in dermatological conditions [1][3]. Group 1: Patient Case Summary - A 22-year-old patient, referred to as Xiao Zhang, experienced a significant decline in vision, ultimately diagnosed with cataracts [1][3]. - The cataract was attributed to over a year of steroid and biological agent use for treating neurodermatitis, which led to the development of steroid-induced cataracts [3]. Group 2: Medical Insights - Steroid-induced cataracts are a common type of cataract resulting from prolonged use of steroid medications, either orally or topically [3]. - The exact mechanism of steroid-induced cataracts is not fully understood, but it may involve glucocorticoid receptor mediation and abnormal cell adhesion [3]. - Patients using steroids for extended periods may face progressive eye-related side effects, necessitating regular eye examinations [4]. Group 3: Treatment and Recovery - The medical team proposed a surgical solution involving femtosecond laser-assisted implantation of a trifocal intraocular lens, which successfully restored the patient's vision to 1.0 within a day post-surgery [3].